Interleukin-6-174 Genotype, Periodontal Disease and Adverse Pregnancy Outcomes: A Pilot Study
Abstract This study was undertaken to investigate whether maternal periodontal disease and variant genotypes of IL-6 gene are associated with adverse pregnancy outcomes. A total of 145 pregnant women were recruited from St Mary’s Hospital, Manchester, UK. Bleeding on probing (BOP) and pocket depth indices were recorded on all teeth. Amplification refractory mutation system-polymerase chain reaction was used for −174 IL-6 genotyping. Birth weight was assessed using the individualized birth ratio (IBR) with intrauterine growth restriction (IUGR) defined as an IBR below the fifth percentile. The G/G genotype results in more BOP % sites in Caucasian(P < 0.001) and Afro-Caribbean pregnant women (P = 0.035). In addition, a marginal significant association between the −174 C/C genotype and IUGR was observed (P = 0.06). The −174* C allele was more frequent in women with IUGR than in normal women (63 vs 37%, P = 0.05). Moreover, the combination between the carriage of −174C allele and increased bleeding sites have increased the risk of IUGR (P = 0.006). Future studies, with a larger sample size, are required to better clarify the relationship between the IL-6 gene polymorphism, periodontal disease, and IUGR..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Journal of clinical immunology - 28(2008), 3 vom: 08. Jan., Seite 237-243 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Dashash, M. [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Anmerkungen: |
© Springer Science+Business Media, LLC 2007 |
---|
doi: |
10.1007/s10875-007-9162-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2049630751 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2049630751 | ||
003 | DE-627 | ||
005 | 20230514053244.0 | ||
007 | tu | ||
008 | 200819s2008 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s10875-007-9162-3 |2 doi | |
035 | |a (DE-627)OLC2049630751 | ||
035 | |a (DE-He213)s10875-007-9162-3-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.00 |2 bkl | ||
100 | 1 | |a Dashash, M. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Interleukin-6-174 Genotype, Periodontal Disease and Adverse Pregnancy Outcomes: A Pilot Study |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © Springer Science+Business Media, LLC 2007 | ||
520 | |a Abstract This study was undertaken to investigate whether maternal periodontal disease and variant genotypes of IL-6 gene are associated with adverse pregnancy outcomes. A total of 145 pregnant women were recruited from St Mary’s Hospital, Manchester, UK. Bleeding on probing (BOP) and pocket depth indices were recorded on all teeth. Amplification refractory mutation system-polymerase chain reaction was used for −174 IL-6 genotyping. Birth weight was assessed using the individualized birth ratio (IBR) with intrauterine growth restriction (IUGR) defined as an IBR below the fifth percentile. The G/G genotype results in more BOP % sites in Caucasian(P < 0.001) and Afro-Caribbean pregnant women (P = 0.035). In addition, a marginal significant association between the −174 C/C genotype and IUGR was observed (P = 0.06). The −174* C allele was more frequent in women with IUGR than in normal women (63 vs 37%, P = 0.05). Moreover, the combination between the carriage of −174C allele and increased bleeding sites have increased the risk of IUGR (P = 0.006). Future studies, with a larger sample size, are required to better clarify the relationship between the IL-6 gene polymorphism, periodontal disease, and IUGR. | ||
650 | 4 | |a Periodontitis | |
650 | 4 | |a IL-6 | |
650 | 4 | |a IUGR | |
650 | 4 | |a immunology | |
650 | 4 | |a pathology | |
700 | 1 | |a Nugent, J. |4 aut | |
700 | 1 | |a Baker, P. |4 aut | |
700 | 1 | |a Tansinda, D. |4 aut | |
700 | 1 | |a Blinkhorn, F. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical immunology |d Springer US, 1981 |g 28(2008), 3 vom: 08. Jan., Seite 237-243 |w (DE-627)168589001 |w (DE-600)779361-3 |w (DE-576)016104072 |x 0271-9142 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2008 |g number:3 |g day:08 |g month:01 |g pages:237-243 |
856 | 4 | 1 | |u https://doi.org/10.1007/s10875-007-9162-3 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4219 | ||
936 | b | k | |a 44.00 |q VZ |
951 | |a AR | ||
952 | |d 28 |j 2008 |e 3 |b 08 |c 01 |h 237-243 |